Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Kentucky · 2025 Regular Session · Bill

HB 469: AN ACT relating to human gene therapy products and declaring an emergency.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 469 is a bill introduced in the Kentucky House on February 12, 2025. According to its official title, it concerns: AN ACT relating to human gene therapy products and declaring an emergency. Most recent recorded action (February 14, 2025): to Health Services (H).

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Create a new section of KRS Chapter 214 to establish legislative intent; define terms; establish that a person in the Commonwealth shall not administer, by any route or modality, any human gene therapy product for any infectious disease indication, regardless of whether the administration is termed an immunization, vaccine, or any other term; exempt human gene therapy products used to treat cancer or genetic disorders; sunset the provisions on July 1, 2035, unless extended by the General Assembly; EMERGENCY.

Sponsors

NameRolePartyChamberDistrict
No sponsor recorded in source data.

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. to Health Services (H)
  2. to Committee on Committees (H)
  3. introduced in House

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source